Nuclear magnetic resonance contrast agents
US5702683A · kind A · utility
6Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 1991 |
| Grant date | Dec 30, 1997 |
| Priority date | — |
| Expiry date | Jan 22, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A family of contrast agents for use in magnetic resonance imaging and a method of enhancing the contrast of magnetic resonance images of an object by incorporating a contrast agent of this invention into the object prior to forming the images or during formation of the images. A contrast agent of this invention is a paramagnetic lanthanide hexaazamacrocyclic molecule, where a basic example has the formula LnC.sub.16 H.sub.14 N.sub.6. Important applications of the invention are in medical diagnosis, treatment, and research, where images of portions of a human body are formed by means of magnetic resonance techniques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.